Publications by authors named "Jonathan Friedberg"

Claim this Profile
E
Erratum: Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma.
Franck Morschhauser, Gilles Salles, Laurie H Sehn, Alex F Herrera, Jonathan W Friedberg

J Clin Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemoimmunotherapy on the SWOG S0016 trial.
Alexey V Danilov, Hongli Li, Mazyar Shadman, Lisa Rimsza, Ahmad Zebari, Jonathan W Friedberg

Haematologica· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing primary mediastinal large B-cell lymphoma based on molecular classification: a multi-center retrospective pilot study.
Michael A Superdock, Lisa M Rimsza, Danielle S Wallace, Myla Strawderman, Colleen A Ramsower, Jonathan W Friedberg

Leuk Lymphoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a gene expression signature to predict early events in patients with follicular lymphoma.
Colleen A Ramsower, George Wright, Hongli Li, James R Cerhan, Matthew J Maurer, Jonathan W Friedberg

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma.
Franck Morschhauser, Gilles Salles, Laurie H Sehn, Alex F Herrera, Jonathan W Friedberg

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sun Sets on Rituximab/Gemcitabine/Oxaliplatin as Bispecific Antibodies Rise: The SUNMO Trial.
Danielle S Wallace, Jonathan W Friedberg

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma.
Matthew J Maurer, Vit K Prochazka, Tarec Christoffer El-Galaly, Christopher R Flowers, Diego Villa, Jonathan W Friedberg

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bringing Trustworthy Artificial Intelligence to the Clinical Forefront at : A Guide for Studies Testing Artificial Intelligence Models.
Ravi B Parikh, Alexia Iasonos, Andrew Ko, Jeremy Warner, Kathy Miller, Jonathan W Friedberg

J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptation and Performance of the Self-Report-Generated Charlson Comorbidity Index in the Lymphoma Epidemiology of Outcomes (LEO) Cohort.
James R Cerhan, Tereza Sokolova, Elliott J Cahn, Mazie Tsang, Christopher S Strouse, Jonathan W Friedberg

Hematol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occurrence and predictors of patient reported fertility discussions in non-Hodgkin lymphoma patients: utilizing the lymphoma epidemiology of outcomes (LEO) cohort study.
Nadia Toumeh, Melissa Larson, Brianna Negaard, Carla Casulo, Sairah Ahmed, Jonathan Friedberg

Leuk Lymphoma· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib added to standard conditioning and as maintenance therapy following autologous hematopoietic stem cell transplantation for relapsed or refractory activated-B-cell type Diffuse Large B-cell lymphoma: primary analysis of the US intergroup double-blind randomized phase III study Alliance A051301/BMT-CTN 1201.
Charalambos Andreadis, Olivia Bobek, Eric D Hsi, Timothy S Fenske, Patrick J Stiff, Jonathan W Friedberg

Leuk Lymphoma· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials.
Simonetta Viviani, Chiara Pavoni, Sally F Barrington, Luca Guerra, Heiko Schöder, Jonathan W Friedberg

Blood Cancer J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826.
Sarah C Rutherford, Hongli Li, Alex F Herrera, Michael LeBlanc, Sairah Ahmed, Jonathan W Friedberg

J Clin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real World Data Identifies Care Needs in Adolescent and Young Adult Patients with Lymphoma: A Matched Cohort Study.
John Mariano, Myla Strawderman, Eric Snyder, Tina Faugh, Danielle S Wallace, Jonathan W Friedberg

J Adolesc Young Adult Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study.
Carrie Thompson, Marek Trněný, Franck Morschhauser, Gilles A Salles, Patrick M Reagan, Jonathan W Friedberg

Blood· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failure.
Emily Anderson, Yun Choi, Rachel J Buchsbaum, Andreas Klein, Bonnie Ky, Jonathan W Friedberg

Leuk Lymphoma· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up.
Eva Domingo-Domènech, Barbara Pro, Tim Illidge, Steven Horwitz, Lorenz Trumper, Jonathan W Friedberg

Blood Cancer J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SWOG 2308: Randomized Phase III Study of Mosunetuzumab Versus Rituximab for Low-Tumor Burden Follicular Lymphoma.
Nilanjan Ghosh, Shay Bellasea, Hongli Li, Adam J Olszewski, Locke Bryan, Jonathan W Friedberg

JCO Oncol Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO Consortium.
Jonathan R Day, Melissa C Larson, Urshila Durani, Jean L Koff, Yucai Wang, Jonathan W Friedberg

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The A-HIPI prediction model in advanced-stage Hodgkin lymphoma: identification of risk groups and creation of an online tool.
Matthew J Maurer, Susan K Parsons, Jenica N Upshaw, Angie Mae Rodday, Raphael Mwangi, Jonathan W Friedberg

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma. Reply.
Alex F Herrera, Michael LeBlanc, Jonathan W Friedberg

N Engl J Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D in patients with low tumor-burden indolent non-Hodgkin lymphoma treated with rituximab therapy (ILyAD): a randomized, phase 3 clinical trial.
Jonathan W Friedberg, Michael T Brady, Myla Strawderman, Brad S Kahl, Izidore S Lossos

EClinicalMedicine· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis.
Brooj Abro, Matthew J Maurer, Thomas M Habermann, W Richard Burack, Jennifer R Chapman, Jonathan W Friedberg

Blood· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.
Alex F Herrera, Michael LeBlanc, Sharon M Castellino, Hongli Li, Sarah C Rutherford, Jonathan W Friedberg

N Engl J Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonally unrelated primary large B-cell lymphomas separated by over a decade involving the central nervous system and testicle: Possible predisposition to lymphomas of immune-privileged sites?
Giby V George, Diana G Aldowitz, Audrey N Jajosky, Danielle S Wallace, W Richard Burack, Jonathan W Friedberg

EJHaem· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis